CN102475276A - 益生菌胶囊 - Google Patents
益生菌胶囊 Download PDFInfo
- Publication number
- CN102475276A CN102475276A CN2010105735434A CN201010573543A CN102475276A CN 102475276 A CN102475276 A CN 102475276A CN 2010105735434 A CN2010105735434 A CN 2010105735434A CN 201010573543 A CN201010573543 A CN 201010573543A CN 102475276 A CN102475276 A CN 102475276A
- Authority
- CN
- China
- Prior art keywords
- bacteria
- probio
- product
- various
- human body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 8
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 8
- 239000002775 capsule Substances 0.000 title claims abstract description 5
- 241000894006 Bacteria Species 0.000 claims abstract description 18
- 201000010099 disease Diseases 0.000 claims abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 14
- 108090000790 Enzymes Proteins 0.000 claims abstract description 8
- 102000004190 Enzymes Human genes 0.000 claims abstract description 8
- 230000000529 probiotic effect Effects 0.000 claims abstract description 6
- 244000005700 microbiome Species 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 3
- 229940088598 enzyme Drugs 0.000 abstract description 6
- 102000013142 Amylases Human genes 0.000 abstract description 4
- 108010065511 Amylases Proteins 0.000 abstract description 4
- 108091005804 Peptidases Proteins 0.000 abstract description 4
- 239000004382 Amylase Substances 0.000 abstract description 3
- 108010059892 Cellulase Proteins 0.000 abstract description 3
- 102000004882 Lipase Human genes 0.000 abstract description 3
- 108090001060 Lipase Proteins 0.000 abstract description 3
- 239000004367 Lipase Substances 0.000 abstract description 3
- 239000004365 Protease Substances 0.000 abstract description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 3
- 235000019418 amylase Nutrition 0.000 abstract description 3
- 229940106157 cellulase Drugs 0.000 abstract description 3
- 235000019421 lipase Nutrition 0.000 abstract description 3
- 229940040461 lipase Drugs 0.000 abstract description 3
- 235000019419 proteases Nutrition 0.000 abstract description 3
- 240000006439 Aspergillus oryzae Species 0.000 abstract description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 abstract description 2
- 241000193755 Bacillus cereus Species 0.000 abstract description 2
- 102100026189 Beta-galactosidase Human genes 0.000 abstract description 2
- 241000186000 Bifidobacterium Species 0.000 abstract description 2
- 108010059881 Lactase Proteins 0.000 abstract description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 abstract description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 abstract description 2
- 241000235342 Saccharomycetes Species 0.000 abstract description 2
- 108010005774 beta-Galactosidase Proteins 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 229940116108 lactase Drugs 0.000 abstract description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 abstract description 2
- 230000000243 photosynthetic effect Effects 0.000 abstract description 2
- 244000063299 Bacillus subtilis Species 0.000 abstract 1
- 235000014469 Bacillus subtilis Nutrition 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 229940111205 diastase Drugs 0.000 abstract 1
- 235000019833 protease Nutrition 0.000 abstract 1
- 230000036541 health Effects 0.000 description 6
- 208000024827 Alzheimer disease Diseases 0.000 description 5
- 206010039966 Senile dementia Diseases 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 201000010538 Lactose Intolerance Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 241000700605 Viruses Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 231100000317 environmental toxin Toxicity 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
一种益生菌胶囊，是目前发明的防治多种疾病的最新产品，在本发明之前，市场上从未发现有同类产品，该产品是由益生菌——双歧杆菌、嗜酸乳杆菌、纳豆芽孢杆菌、蜡样芽孢杆菌、酵母菌、米曲酶菌、糖化酶菌、光合菌等组成。这些有益菌具有多种活性，进入人体后可杀死各种有害微生物和病菌，并能产生多种活性酶，如：淀粉酶、蛋白酶、脂肪酶、纤维素酶、乳糖酶、肽酶等，维持人体微生态平衡从而能防止多种疾病的发生。
Description
一种益生菌胶囊，是目前发明的防治多种疾病最新产品，该产品能防治癌症、冠心病、孤僻症、乳糖不耐受症、肠胃病、糖尿病、老年痴呆症等。在本发明之前，市场上从未发现有同类产品。该产品是由多种益生菌成分组成。其中有：双歧杆菌、嗜酸乳杆菌、纳豆芽孢杆菌、蜡样芽孢杆菌、酵母菌、米曲酶菌、糖化酶菌、光合菌等组成。这些细菌是有益于人体健康的细菌，即称之为：“益生菌”。益生菌具有多种活性酶和细菌活性因子，细菌数量高达3000亿/克。这些活菌进入人体肠胃中能生长繁殖并杀死肠胃中各种有害微生物和病菌，还能产生各种活性酶。如：淀粉酶、蛋白酶、脂肪酶、纤维素酶、乳糖酶、肽酶等。益生菌具有很多功能，所以它能防治多种疾病。
一、可以防治癌症
科学研究认为，益生菌在防御癌细胞突变过程中扮演着积极角色。首先，益生菌可以制造防御物质，并为之解码；其次，它可以吸收有毒物质，并减弱其毒性；更重要的是，它会让身体远离有害细菌，而这些有害物会吸附无害物，并将之转化为致癌物。可见，益生菌可以防御并化解有害化合物对DNA的攻击，从而避免基因突变。
二、可以防治冠心病
补充益生菌可以调节肠道内的微生态平衡，并引发人体内的胆固醇调配机制的变化，从而有效降低体内胆固醇含量。益生菌还可以有效降血压。可以说，益生菌已成为对抗冠心病的神奇武器。它可使冠心病的犯病几率降低76％。
三、可以防治孤僻症
第一，摄取益生菌能够修复肠漏，设置物理障碍，防止病原体侵入体内，从而促进身体的自我预防能力。第二，更为重要的是益生菌的排毒功效。它可以通过使用摩尔因子将体内的有机汞转化为挥发性的自然汞和无毒的无机汞，从而治疗孤僻症症状。
四、可以防治乳糖不耐受症
乳糖不耐受症是因为体内缺少消化乳糖的酶，而益生菌中恰好含有大量的酶—乳糖酶、脂肪酶、淀粉酶、蛋白酶、纤维素酶、肽酶，等等。益生菌进入体内进行分解，释放出其中的酶，同人体组织一起反应。这不仅可以治疗乳糖不耐受症，还能提升人体其它方面的机能。
五、可以防治肠胃病
疾病源自菌群的失衡。只要有一种病原细菌在肠中的数量增加就会引发肠易激综合症。益生菌疗法不仅可以赶走和杀死肠内的有害细菌，还可以改变胃肠道的PH值，促使身体产生某种抗体从而矫正身体对有害细菌产生的过度免疫反应，并消除炎症，还你一个健康的胃肠道。
六、可以防治糖尿病
葡萄糖是益生菌的最爱。如果周围有大量葡萄糖的话，益生菌甚至不碰其他糖类。因此，如果体内有大量益生菌存在，那么在体内输送的葡萄糖就会减少，血糖指数自然会下降。血糖下降以后，肝脏用来转化为脂肪的肝糖也减少了，体重也会得以控制。
七、可以防治老年痴呆症
在一定程度上，益生菌能够扭转老年痴呆症的退化过程。摄入大量的益生菌，可将其中所含的酶吸收进循环系统，可以令许多有害成分(如肽)在囤积和生成血小板之前就被消化掉，而长期的血小板囤积是老年痴呆症的主要病因。
本发明的目的就是发明一种益生菌产品，来防止多种疾病的发生。
原料、配方比、制备方法、配方原理
原料、配方比：
益生菌每颗0.25克(内含750株活菌)
制备方法：将益生菌装入胶囊，进行包装，即成合格产品。
配方原理：科学家们通过临床研究，揭示了一个伟大的事实，人体微生态失衡，是产生多种疾病的一个重要因素。人体内的微生物有上千亿之多，其中有益菌群(益生菌)和有害菌群(病毒)的数量维系了人体微生态的平衡。随着低质量饮食和环境毒素日益增多，病毒会超过并破坏益生菌，就会造成体内微生态系统的失衡，于是各种疾病——癌症、冠心病、肥胖症、孤僻症、糖尿病、老年痴呆症等就会接踵而至。
Claims (3)
1.一种益生菌胶囊，其特征在于：
(1)该产品是由益生菌加工而成
(2)该产品每颗内含750亿活菌因子，它可以杀死人体内各种有害微生物和病菌，并能产生各种活性酶维持体内微生态平衡。
2.根据权利要求(1)所述，该产品是由益生菌配制而成，每颗产品内含活菌750亿株。
3.根据权利要求(2)所述，该产品由于能杀死体内各种有害微生物和病菌，并能产生各种活性酶维持体内微生态平衡。所以，它能防止多种疾病的发生。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105735434A CN102475276A (zh) | 2010-11-27 | 2010-11-27 | 益生菌胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105735434A CN102475276A (zh) | 2010-11-27 | 2010-11-27 | 益生菌胶囊 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102475276A true CN102475276A (zh) | 2012-05-30 |
Family
ID=46088144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105735434A Pending CN102475276A (zh) | 2010-11-27 | 2010-11-27 | 益生菌胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102475276A (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102973614A (zh) * | 2012-12-28 | 2013-03-20 | 蒋常德 | 一种防治老年痴呆症的益生菌活性保健液及其制备方法 |
| CN103876151A (zh) * | 2014-04-09 | 2014-06-25 | 吉林大学 | 一种益生菌微生态胶囊剂及其制备方法 |
| CN109172612A (zh) * | 2018-10-26 | 2019-01-11 | 北京科技大学 | 一种基于光合细菌的防治精神障碍的生物制剂及其应用 |
| CN113142507A (zh) * | 2021-05-31 | 2021-07-23 | 成都大学 | 一种肉干表面微生物固色方法 |
| CN113230278A (zh) * | 2021-03-09 | 2021-08-10 | 李春孝 | 一种化能自养型细菌的应用 |
| CN115058305A (zh) * | 2022-05-31 | 2022-09-16 | 四川轻化工大学 | 一种益生菌米酒曲的制备方法及其应用 |
-
2010
- 2010-11-27 CN CN2010105735434A patent/CN102475276A/zh active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102973614A (zh) * | 2012-12-28 | 2013-03-20 | 蒋常德 | 一种防治老年痴呆症的益生菌活性保健液及其制备方法 |
| CN102973614B (zh) * | 2012-12-28 | 2014-12-31 | 张华� | 一种防治老年痴呆症的益生菌活性保健液及其制备方法 |
| CN103876151A (zh) * | 2014-04-09 | 2014-06-25 | 吉林大学 | 一种益生菌微生态胶囊剂及其制备方法 |
| CN109172612A (zh) * | 2018-10-26 | 2019-01-11 | 北京科技大学 | 一种基于光合细菌的防治精神障碍的生物制剂及其应用 |
| CN109172612B (zh) * | 2018-10-26 | 2022-03-15 | 北京科技大学 | 一种基于光合细菌的防治精神障碍的生物制剂及其应用 |
| CN113230278A (zh) * | 2021-03-09 | 2021-08-10 | 李春孝 | 一种化能自养型细菌的应用 |
| CN113142507A (zh) * | 2021-05-31 | 2021-07-23 | 成都大学 | 一种肉干表面微生物固色方法 |
| CN115058305A (zh) * | 2022-05-31 | 2022-09-16 | 四川轻化工大学 | 一种益生菌米酒曲的制备方法及其应用 |
| CN115058305B (zh) * | 2022-05-31 | 2023-11-17 | 四川轻化工大学 | 一种益生菌米酒曲的制备方法及其应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Oak et al. | The effects of probiotics in lactose intolerance: A systematic review | |
| Priyodip et al. | Phytases of probiotic bacteria: characteristics and beneficial aspects | |
| Shruthi et al. | Exploring biotechnological and functional characteristics of probiotic yeasts: A review | |
| CN101688171B (zh) | 益生双歧杆菌菌株 | |
| CN102475276A (zh) | 益生菌胶囊 | |
| Suissa et al. | Molecular genetics for probiotic engineering: dissecting lactic acid bacteria | |
| KR20180133443A (ko) | 신규한 세균 종 | |
| Pihurov et al. | Novel insights for metabiotics production by using artisanal probiotic cultures | |
| Ramlucken et al. | Production and stability of a multi-strain Bacillus based probiotic product for commercial use in poultry | |
| Szlufman et al. | Role of probiotic bacilli in developing synbiotic food: Challenges and opportunities | |
| Vijayaraghavan et al. | Novel sequential screening and enhanced production of fibrinolytic enzyme by Bacillus sp. IND12 using response surface methodology in solid‐state fermentation | |
| Zhao et al. | Probiotic role and application of thermophilic Bacillus as novel food materials | |
| CN103263444B (zh) | 预防和治疗山羊应激性腹泻的微生态复方制剂及其制备方法 | |
| CN110881577A (zh) | 一种防控非洲猪瘟的生物饲料及其制备方法 | |
| CN104940240B (zh) | 一种用于解酒护肝的益生菌制剂及其制备方法和应用 | |
| Liang et al. | Progress of research and application of Heyndrickxia coagulans (Bacillus coagulans) as probiotic bacteria | |
| CN111374304A (zh) | 利用枯草芽孢杆菌的食用酶食品的制备方法 | |
| CN102783635A (zh) | 广谱防病劲体胶囊 | |
| CN105767876B (zh) | 一种燕麦麸皮发酵咀嚼片的制备方法 | |
| Maresca et al. | Harnessing the dual nature of W. coagulans for sustainable production of biomaterials and development of functional food | |
| Al-qwabah et al. | Bacillus atrophaeus A7 Crude Chitinase: Characterization and Potential Role against Drosophila melanogaster Larvae. | |
| Barman et al. | Amylolytic activity and its parametric optimization of an endophytic bacterium Bacillus subtilis with an ethno-medicinal origin | |
| CN107467670B (zh) | 一种益生菌制剂及其制备方法与应用 | |
| Sen et al. | Molecular characterization and in vitro analyses of a sporogenous bacterium with potential probiotic properties | |
| KR102217456B1 (ko) | 미생물을 이용한 꿀의 발효방법, 이에 의해 제조된 발효꿀 및 이를 원료로 하는 제품 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120530 |